1037397-92-4

Upstream product

• 1040353-71-6 N-[2-amino-4-chloro-6-(3-methyl-4-nitro-benzylamino)-pyrimidin-5-yl]-formamide 
• 55583-59-0 2,5-diamino-4,6-dichloropyrimidine 
• 1037397-91-3 (3-methyl-4-nitrophenyl)methanamine hydrochloride 

Downstream Products

• 442908-07-8 7-(furan-2-yl)-3-(3-methyl-4-nitrobenzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine 

Relevant academic research and scientific papers

POLYMORPHS AND SOLVATES OF A PHARMACEUTICAL AND METHODS OF MAKING

Polymorphic and solvated forms of solid 3-(4-amino-3-methylbenzyl)-7-(furan-2- yl)-3H-[l,2,3]triazolo[4,5-d]pyrimidin-5-amine, and methods of making them, are described.

PHARMACEUTICALS, COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

Compounds that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.